145 related articles for article (PubMed ID: 3147905)
1. Effect of cholestyramine on plasma cholecystokinin and pancreatic polypeptide levels, and exocrine pancreatic secretion.
Koop I; Fellgiebel A; Koop H; Schafmayer A; Arnold R
Eur J Clin Invest; 1988 Oct; 18(5):517-23. PubMed ID: 3147905
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans.
Koop I; Dorn S; Koop H; Witzleb S; Beglinger C; Schafmayer A; Arnold R
Dig Dis Sci; 1991 Nov; 36(11):1625-32. PubMed ID: 1935502
[TBL] [Abstract][Full Text] [Related]
3. Chronic effect of oral cholestyramine, a bile salt sequestrant, and exogenous cholecystokinin on insulin release in rats.
Kogire M; Gomez G; Uchida T; Ishizuka J; Greeley GH; Thompson JC
Pancreas; 1992; 7(1):15-20. PubMed ID: 1557341
[TBL] [Abstract][Full Text] [Related]
4. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.
Koop I; Schindler M; Bosshammer A; Scheibner J; Stange E; Koop H
Gut; 1996 Nov; 39(5):661-7. PubMed ID: 9026479
[TBL] [Abstract][Full Text] [Related]
5. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
[TBL] [Abstract][Full Text] [Related]
6. Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion.
Thimister PW; Hopman WP; Loualidi A; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB
Scand J Gastroenterol; 1997 Aug; 32(8):778-84. PubMed ID: 9282969
[TBL] [Abstract][Full Text] [Related]
7. Plasma CCK levels in patients with pancreatic insufficiency.
Bozkurt T; Adler G; Koop I; Koop H; Türmer W; Arnold R
Dig Dis Sci; 1988 Mar; 33(3):276-81. PubMed ID: 3342719
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
[TBL] [Abstract][Full Text] [Related]
9. Diurnal profile of pancreatic exocrine secretion and plasma levels of gut hormones (cholecystokinin and pancreatic polypeptide).
Nakano I; Funakoshi A; Shinozaki H; Miyazaki K; Tateishi K; Hamaoka T
Gastroenterol Jpn; 1987 Dec; 22(6):748-55. PubMed ID: 3443256
[TBL] [Abstract][Full Text] [Related]
10. The influence of bile acids on the regulation of exocrine pancreatic secretion and on the plasma concentrations of neurotensin and CCK in dogs.
Nustede R; Schmidt WE; Köhler H; Fölsch UR; Schafmayer A
Int J Pancreatol; 1993 Feb; 13(1):23-30. PubMed ID: 8454915
[TBL] [Abstract][Full Text] [Related]
11. Effect of acute hyperglycemia on basal and cholecystokinin stimulated exocrine pancreatic secretion in humans.
Lam WF; Masclee AA; de Boer SY; Souverijn JH; Lamers CB
Life Sci; 1997; 60(24):2183-90. PubMed ID: 9188761
[TBL] [Abstract][Full Text] [Related]
12. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
[TBL] [Abstract][Full Text] [Related]
13. Effect of acute hyperglycaemia on basal and fat-induced exocrine pancreatic secretion in humans.
Lam WF; Muller ES; Souverijn JH; Lamers CB; Masclee AA
Clin Sci (Lond); 1997 Dec; 93(6):573-80. PubMed ID: 9497795
[TBL] [Abstract][Full Text] [Related]
14. Exocrine pancreatic secretion and plasma levels of cholecystokinin, pancreatic polypeptide, and somatostatin after single and combined intraduodenal application of different bile salts in man.
Riepl RL; Fiedler F; Kowalski C; Teufel J; Lehnert P
Ital J Gastroenterol; 1996; 28(8):421-9. PubMed ID: 9032583
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of pancreatic growth and gallbladder contractility by bile salts.
Gomez G; Townsend CM; Maani R; Singh P; Greeley GG; Thompson JC
Am J Surg; 1989 Jan; 157(1):20-6. PubMed ID: 2910123
[TBL] [Abstract][Full Text] [Related]
16. Intracolonic infusion of bile salt stimulates release of peptide YY and inhibits cholecystokinin-stimulated pancreatic exocrine secretion in conscious dogs.
Izukura M; Hashimoto T; Gomez G; Uchida T; Greeley GH; Thompson JC
Pancreas; 1991 Jul; 6(4):427-32. PubMed ID: 1876599
[TBL] [Abstract][Full Text] [Related]
17. Reduced cholecystokinin mediates the inhibition of pancreatic growth induced by bile salts.
Gomez G; Townsend CM; Green DW; Rajaraman S; Greeley GH; Thompson JC
Am J Physiol; 1990 Jul; 259(1 Pt 1):G86-92. PubMed ID: 1695489
[TBL] [Abstract][Full Text] [Related]
18. Effects of ethanol on meal-stimulated secretion of pancreatic polypeptide and cholecystokinin: comparison of healthy volunteers, heavy drinkers, and patients with chronic pancreatitis.
Hirano H; Shimosegawa T; Meguro T; Shiga N; Koizumi M; Toyota T
J Gastroenterol; 1996 Feb; 31(1):86-93. PubMed ID: 8808434
[TBL] [Abstract][Full Text] [Related]
19. Effect of nicotine on basal and bombesin stimulated canine plasma levels of gastrin, cholecystokinin and pancreatic polypeptide.
Chowdhury P; Inoue K; Rayford PL
Peptides; 1985; 6(1):127-32. PubMed ID: 3991359
[TBL] [Abstract][Full Text] [Related]
20. Role of bile acids in the control of pancreatic secretion and CCK release.
Koop I
Eur J Clin Invest; 1990 Oct; 20 Suppl 1():S51-7. PubMed ID: 2124998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
